IBB

iShares NASDAQ Biotechnology ETF

The iShares Nasdaq Biotechnology Index Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of companies primarily engaged in the biotechnology industry, as represented by the NASDAQ Biotechnology Index.


Passive, Concentrated

MANAGEMENT MATRIX

IBBQ

CLOSEST COMP

FACTOR SCORECARD

SIZE
VALUE
YIELD
MOMENTUM
VOLATILITY
QUALITY
Fund Basics
Fund sponsorBarclays Global Investors
CategoryUS Equities
Asset classEquity
Websitelink...
Inception dateFeb 05, 2001
Assets (mns)$7,386
Expense ratio44 bp
CurrencyUSD
Sector Breakdown
Fund Structure
RegulationOpen-Ended Fund
DistributionsQuarterly
Taxation1099
Stock selectionNASDAQ - Listed
WeightingMarket Cap
Holdings TransparencyFull
Derivatives-basedNo
Options availableYes
Currency hedgedNo
Fund of fundsNo
Top 10 Holdings Complete list  + 
GILEAD SCIENCES INC 8.0 %
AMGEN INC 7.8 %
VERTEX PHARMACEUTICALS INC 7.6 %
REGENERON PHARMACEUTICALS 7.3 %
MODERNA, INC. 4.1 %
BIOGEN IDEC INC 4.0 %
IQVIA HOLDINGS INC 3.5 %
ILLUMINA INC 3.1 %
BIONTECH SE SPONSORED ADR 2.6 %
SEATTLE GENETICS INC 2.6 %
Constituent Breakdown
Number of holdings369
Herfindahl-Hirschman Index 343
Wgt avg mkt cap (mns)$39,224
Large cap (>$10bn)69.1%
Mid cap ($2-10bn)18.6%
Small cap (<$2bn)11.2%
Developed mkts.99.7%
Emerging mkts.0.3%
Country Exposure
UNITED STATES 87.7 %
GERMANY 2.7 %
DENMARK 2.2 %
NETHERLANDS 1.7 %
CHINA 1.4 %
BRITAIN 1.3 %
IRELAND 0.7 %
CANADA 0.6 %
Historical Performance


Standardized Annual Returns (as of 08/31/2022)
YTD1 YR2 YR3 YR5 YR10 YRIncep.
-20.3% -29.4% -5.2% 5.9% 2.0% 10.5% 6.5%
Market Correlations
versus...BetaR-squared
S&P 5000.6940%
MSCI EAFE0.6433%
MSCI Emg Mkts0.5627%
Liquidity Measures
Avg. volume (000)1,935
Turnover3.1%
Avg. Bid/Ask (% of price)0.02%
ADV of underlying (mns)$9,375
Technical Indicators
Recent close$116.96
30d moving avg.$122.00
Annualized volatility20.9%
Relative strength (RSI)39
Short interest (ETF)12.4%
Short interest (underlying)4.8%
Distributions
Assets Under Management (mns)

Money Flows (mns)

Short Interest (as % of shares outstanding)

Long Money Flows (mns)

Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial

Risk and Returns: IBB vs. Comps (1 YR)

Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.

Content on this tab for Individual & Professional subscribers only. Start your FREE trial

Results & Estimates
  2017 2018 2019 2020 2021 2022E 2023E  
Sales per share -- -- -- -- -- -- --
  change (%) -- -- -- -- -- -- --
Earnings per share -- -- -- -- -- -- --
  change (%) -- -- -- -- -- -- --
Dividends per share -- -- -- -- -- -- --
  change (%) -- -- -- -- -- -- --
Book value per share -- -- -- -- -- -- --
  change (%) -- -- -- -- -- -- --
Return on Equity
Net Margins
EPS Revision Activity (6 mo. ago = 100%)
Compound Annual Growth Rates

Content on this tab for Individual & Professional subscribers only. Start your FREE trial

Valuation Metrics
  2021 2022E Fwd Est 2023E
Price-to-sales --x --x --x --x
Price-to-earnings --x --x --x --x
Price-to-cash flow --x --x --x --x
Price-to-growth --x --x --x --x
Price-to-book value --x --x --x --x
Yield --% --% --x --%
5.2 78.3 4.7 0.8% --
Based on closing prices from 9/30/2022
Historical Valuation Trends Sample data. Subscribe for access.

SHOWING:
Price-to-Earnings
IBB



Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.

Some content on this tab for Individual & Professional subscribers only. Start your FREE trial

ETF Research Center Fund Rating

Our measure of an ETF's overall investment merit

ALTAR Score™

IBB

-0.3%

Cat. Avg

7.4%

Fund Category: US Equities

Avg. Return on Equity--%
Divided by: Fwd. P/BV--x
Less: Expenses-- bp
Equals: ALTAR Score™-0.3%
Recommendation

AVOID

Not worthwhile for most investors. A rating of AVOID is assigned to ETFs with ALTAR Scores in the lowest quintile (the bottom 20%) of their category. Often, funds in this category consist of stocks with little if any history or expectation of profitability, and as a result our fundamentally-driven analysis may be less relevant.

Category Overview
There are 875 funds in the US Equities category, with an average ALTAR Score™ of 7.4% and a standard deviation of 3.2%. IBB's ALTAR Score™ is approximately 2.4 standard deviations below the category average. This places IBB in the 1st percentile among funds in the category.
Consensus Recommendation

Sell-side recommendations on the ETF's individual constituents

Composite
IBB
Peer Average
SELL
U/W
HOLD
O/W
BUY



Recent Trends


Breakdown

 

Market Activity
Latest price
Change
Volume
Bid/Ask Spread
Update
Today's Trading

Trading data provided for free by IEX. By accessing this data you agree to abide by their Terms of Service.


Total Cost of Ownership (TCO) Comparison
Expense (bp)
(A)
Avg. Bid/Ask (bp)
(B)
TCO (bp)
(A)+(B)
IBB 44.0 1.8 45.8
Peer Avg. -- -- --
  For a detailed cost analysis of this and any other ETF use the TCO Comparison Tool .
Fundamental data for individual fund constituents sourced from FactSet Research Systems.